82121-06-0

Basic information

• Product Name: 7-BROMO-4-HYDROXYQUINOLINE-3-CARBOXYLIC ACID
• Synonyms: 7-BROMO-4-HYDROXYQUINOLINE;7-BROMO-4-HYDROXYQUINOLINE-3-CARBOXYLIC ACID;BUTTPARK 100\01-52;BUTTPARK 89\01-98;7-Bromo-4-quinolinol;8-aminoquinolin-4-ol;4-Quinolinol, 7-bromo-
• CAS NO: 82121-06-0
• Molecular Formula: C₉H₆BrNO
• Molecular Weight: 224.06
• EINECS: -0
• Mol File: 82121-06-0.mol
• Article Data: 18

Chemical Properties

• Melting Point: 279-281 °C
• Boiling Point: 370.732oC at 760 mmHg
• Flash Point: 178.013oC
• Appearance: /
• Density: 1.705g/cm3
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.718
• Storage Temp.: Inert atmosphere,Room Temperature
• PKA: 3.83±0.40(Predicted)
• CAS DataBase Reference: 7-BROMO-4-HYDROXYQUINOLINE-3-CARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 7-BROMO-4-HYDROXYQUINOLINE-3-CARBOXYLIC ACID(82121-06-0)
• EPA Substance Registry System: 7-BROMO-4-HYDROXYQUINOLINE-3-CARBOXYLIC ACID(82121-06-0)

Safety Data

• Hazard Codes: Xn
• Statements: 22-41
• Safety Statements: 26-39
• WGK Germany: 3
• Hazardous Substances Data: 82121-06-0(Hazardous Substances Data)

Usage

Chemical Properties

Class color solid

InChI:InChI=1/C9H6BrNO/c10-6-1-2-7-8(5-6)11-4-3-9(7)12/h1-5H,(H,11,12)

Upstream product

• 591-19-5 m-Bromoaniline 
• 99-90-1 para-bromoacetophenone 
• 73387-60-7 (2E)-1-(4-bromophenyl)-3-(dimethylamino)prop-2-en-1-one 
• 208580-23-8 7-bromo-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ethyl ester 
• 351893-47-5 ethyl α-carbethoxy-β-m-bromoanilinoacrylate 
• 723280-91-9 5-(((3-bromophenyl)amino)methylene)-2,2-dimethyl-1,3-dioxane-4,6-dione 
• 2033-24-1 cycl-isopropylidene malonate 
• 149-73-5 trimethyl orthoformate 
• 153952-03-5 7-bromo-4-hydroxy-quinoline-2-carboxylic acid ethyl ester 
• 208580-23-8 ethyl 7-bromo-4-hydroxyquinoline-3-carboxylate 
• 134785-82-3 7-bromo-4-hydroxy-quinoline-2-carboxylic acid 
• 860205-92-1 7-bromo-4-hydroxy-3-quinolinecarboxylic acid 

Downstream Products

• 723280-94-2 7-bromo-3-nitroquinolin-4-ol 
• 1445786-68-4 3-((3-carbamoyl-7-(2,4-dimethoxypyrimidin-5-yl)-3-sulfamoylquinolin-4-yl)amino)-5-(cyclohexylmethoxy)benzoic acid 
• 1445789-28-5 methyl 3-((3-carbamoyl-7-(2,4-dimethoxypyrimidin-5-yl)-3-sulfamoylquinolin-4-yl)amino)-5-(cyclohexylmethoxy)benzoate 
• 1445786-87-7 7-(2,4-dimethoxypyrimidin-5-yl)-4-((3-(hydroxymethyl)phenyl)amino)quinoline-3-sulfonamide 
• 1445787-13-2 4-((3-cyclopentyl-5-(hydroxymethyl)phenyl)amino)-7-(2,4-dimethoxypyrimidin-5-yl)quinoline-3-sulfonamide 
• 1445787-25-6 4-((3-(1H-tetrazol-5-yl)phenyl)amino)-7-(2,4-dimethoxypyrimidin-5-yl)quinoline-3-sulfonamide 
• 1445787-44-9 3-((7-(2,4-dimethylpyrimidin-5-yl)-3-sulfamoylquinolin-4-yl)amino)-5-isopropoxybenzoic acid 
• 1445790-89-5 methyl 3-((7-bromo-3-sulfamoylquinolin-4-yl)amino)-5-isopropoxybenzoate 
• 1445790-91-9 methyl 3-((7-(2,4-dimethylpyrimidin-5-yl)-3-sulfamoylquinolin-4-yl)amino)-5-isopropoxybenzoate 
• 1445788-38-4 7-(2,4-dimethoxypyrimidin-5-yl)-4-((3-((4-fluorophenyl)amino)-5-(2H-tetrazol-5-yl)phenyl)amino)quinoline-3-sulfonamide 
• 1445786-52-6 3-(cyclohexyloxy)-5-((7-(2,4-dimethoxypyrimidin-5-yl)-3-sulfamoylquinolin-4-yl)amino)benzoic acid 
• 1445788-90-8 methyl 3-(cyclohexyloxy)-5-((7-(2,4-dimethoxypyrimidin-5-yl)-3-sulfamoylquinolin-4-yl)amino)benzoate 
• 1445786-56-0 3-(cyclopentyloxy)-5-((7-(2,4-dimethoxypyrimidin-5-yl)-3-sulfamoylquinolin-4-yl)amino)benzoic acid 
• 1445786-58-2 4-((3-(cyclohexyloxy)phenyl)amino)-7-(2,4-dimethoxypyrimidin-5-yl)quinoline-3-sulfonamide 

Relevant articles and documents

PYRIDONE COMPOUNDS AND METHODS OF USE IN THE MODULATION OF A PROTEIN KINASE

The present disclosure relates generally to compounds and pharmaceutical compositions suitable as modulators of protein kinases, and methods for their use in treating disorders mediated, at least in part by, protein kinases.

APOPTOSIS SIGNAL-REGULATING KINASE 1 (ASK 1) INHIBITOR COMPOUNDS

Described herein are ASK1 inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with ASK1 activity.

For antibacterial chlorine oxygen kui derivatives

The invention relates to an oxo-quinoline derivative with activity of resisting bacterial infection relevant diseases such as helicobacter pylori (Hp) infection disease. The invention specifically relates to a compound as shown in formula I in the specification, and a pharmaceutically acceptable salt, solvate or prodrug thereof, wherein R is selected from hydrogen, -C alkyl, -C alkenyl, -C alkynyl, or -C alkyl-phenyl, and the alkyl, alkenyl, alkynyl and phenyl can be randomly substituted by halogen, nitro, cyan, hydroxyl, -C alkoxy and phenyl; R is selected from hydrogen, -CONHR and -COOR, R and R are independently selected from -C alkyl and -C alkyl amino, and the amino is randomly substituted by one to two -C alkyls; R is selected from halogen, -C alkoxy, morpholinyl or piperazinyl.